In the latter instance, we inferred that a pathogenic stop-gain mutation in RNF43 (R132*), which occurs in nearly 10% of colorectal cancer cases with RNF43 mutations (108), facilitates Wnt ligand-dependent growth. Here, RNF43 is linked to colorectal cancer.